Le Lézard
Classified in: Science and technology
Subjects: Conference, Event, Product/Service, Trade Show

Majesco Gears Up for InsureTech Connect 2021


Majesco, a global leader of cloud insurance software solutions for insurance business transformation, today announced its continued commitment and active participation at InsureTech Connect 2021 as a silver level thought leadership sponsor. This annual event held at the Mandalay Bay in Las Vegas, from Monday, October 4th through Wednesday, October 6th, welcomes over 5,000 attendees to explore and exchange information on today's new innovations and best practices across all segments of the industry.

"We're proud to once again actively participate in this year's InsureTech Connect and excited to be back in-person to collaborate and meet with some of the industry's brightest minds," says Adam Elster, CEO of Majesco. "Our continued commitment to this event and leadership in the InsurTech space reinforces our dedication to enabling the insurance industry to seize the opportunities and navigate a path to the future that embraces speed, agility and innovation for today and tomorrow."

Participants in the event can connect with the Majesco team at booth #846 to discuss and understand how investing in the right solutions to build a field of insurance dreams for P&C and L&A and Group segments to enable growth, accelerate innovation and adapt rapidly to market changes can provide customers what they want, need and expect digitally. In this era of insurance, customers are in the driver's seat. They expect personalized products and services to meet their risk profile, leverage data intelligently, be friction-free, be available via multi-channels and provide real-time, digital engagement.

During the event, Majesco is sponsoring a panel on Tuesday, October 5th from 10:30 ? 11:05 PDT titled, "Accelerating P&C Insurance Industry Transformation to Thrive in a New Digital and Data Arms Race." Hosted by Denise Garth, Chief Strategy Officer at Majesco and Top 50 InsurTech Influencer, she is joined by industry leaders and innovators Gail McGiffin, Chief Information & Operations Officer at Vantage Group Holdings Ltd., and Arlene Kern, Innovation Executive & SVP at Munich Reinsurance America, Inc. Together they will discuss and highlight the evolving P&C insurance landscape, entry of new players within and outside the industry, changing customer expectations, and the acceleration of new technology and innovative products. The ripple effect is the start of a digital and data arms race no longer just in the personal and small commercial lines, but now in mid-large commercial and specialty insurance, separating front runners who will thrive from those left trailing and/or ultimately risk becoming increasingly irrelevant.

If you're looking for information on how to build your field of insurance dreams with market-leading, next-gen solutions, stop by our booth or join us for the panel session at the world's largest InsurTech event.

About Majesco

Majesco is the leading software partner to both the P&C and L&A insurance markets to modernize, optimize and innovate their businesses at speed and scale. Over 330 insurers, from greenfields, start-ups and MGAs to the largest insurers, reinsurers and brokers use Majesco's next generation SaaS platform solutions of core, data, and analytics, digital, distribution, absence management and a rich ecosystem marketplace of established and InsurTech partners to build the future of insurance.

Our technology, expertise and leadership help insurers innovate and connect to build the future of their business. With over 825 successful implementations and over 65% of our customers on Cloud with Majesco platform solutions, together we have an amazing track record of innovation and real-world results. For more details on Majesco, please visit www.majesco.com.


These press releases may also interest you

at 08:25
Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it has dosed the first Canadian subject in its Phase 1 / 2 clinical trial (ABA-1, CLARA) of AURN001, a cell...

at 08:20
The "Highly Potent API Market - A Global and Regional Analysis: Focus on Type, Type of Synthesis, Therapeutic Area, Type of Manufacturing, End User, and Country - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's...

at 08:15
Keysight Technologies , today announced its intention to acquire the entire issued and to be issued share capital of Spirent Communications PLC (London Stock Exchange Symbol: SPT) ("Spirent") for a cash consideration of 199 pence per Spirent share...

at 08:15
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces that it will be attending the LSX World Congress (29-30 April) and presenting at Bio?quity Europe (12-14 May). The...

at 08:15
Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a potential new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced multiple presentations highlighting positive efficacy and safety...

at 08:15
Nuvation Bio Inc. , a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the appointment of Colleen Sjogren as Chief Commercial Officer. Ms....



News published on and distributed by: